Table 1. Recommended Immunization Schedule with Human Papillomavirus Vaccines.

Recommended groups	Recommended immunization schedule	Vaccine(s) and NACI evidence grade
Healthy (immunocompetent, non-HIV infected) Females 9-14 years of age (and healthy females >15 years of age in whom the first dose was administered between 9-14 years of age)	2- or 3-dose schedule	HPV2 or HPV4 (Grade A)
	3-dose schedule	HPV9 (Grade B)
Healthy (immunocompetent, non-HIV infected) Females >15 years of age	3-dose schedule	HPV2 or HPV4 (Grade A) or HPV9 (Grade B)
Healthy (immunocompetent, non-HIV infected) Males 9-14 years of age (and healthy males >15 years of age in whom the first dose was administered between 9-14 years of age)	2- or 3-dose schedule	HPV4 (Grade B)
	3-dose schedule	HPV9 (Grade B)
Healthy (immunocompetent, non-HIV infected) Males >15 years of age	3-dose schedule	HPV4 or HPV9 (Grade B)
Immunocompromised individuals and immunocompetent HIV-infected individuals	3-dose schedule	HPV2, HPV4 or HPV9 in females; HPV4 or HPV9 in males Grade I

Abbreviations: HPV, human papillomavirus; HIV, human immunodeficiency virus